FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970514250> ?p ?o ?g. }

• W1970514250 abstract "Fenoldopam mesylate, a selective dopamine1-receptor agonist, is used by intravenous infusion to treat hypertension in adults. Fenoldopam is not approved by the FDA for use in children; reports describing its use in pediatrics are limited. In a multi-institutional, placebo controlled, double-blind, multi-dose trial we determined the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics and side-effect profile of fenoldopam in children. Seventy seven (77) children from 3 weeks to 12 years of age scheduled for surgery in which deliberate hypotension would be induced were enrolled. Patients were randomly assigned to one of five, blinded treatment groups (placebo or fenoldopam 0.05, 0.2, 0.8, or 3.2 mcg/kg/min iv) for a 30-minute interval after stabilization of anesthesia and placement of vascular catheters. Following the 30-minute blinded interval, investigators adjusted the fenoldopam dose to achieve a target mean arterial pressure in the open-label period until deliberate hypotension was no longer indicated (e.g., muscle-layer closure). Mean arterial pressure and heart rate were continuously monitored and were the primary endpoints. Seventy-six children completed the trial. Fenoldopam at doses of 0.8 and 3.2 mcg/kg/min significantly reduced blood pressure (p < 0.05) during the blinded interval, and doses of 1.0–1.2 mcg/kg/min resulted in continued control of blood pressure during the open-label interval. Doses greater than 1.2 mcg/kg/min during the open-label period resulted in increasing heart rate without additional reduction in blood pressure. Fenoldopam was well-tolerated; side effects occurred in a minority of patients. The PK/PD relationship of fenoldopam in children was determined. Fenoldopam is a rapid-acting, effective agent for intravenous control of blood pressure in children. The effective dose range is significantly higher in children undergoing anesthesia and surgery (0.8–1.2 mcg/kg/min) than as labeled for adults (0.05–0.3 mcg/kg/min). The PK and side-effect profiles for children and adults are similar." @default.
• W1970514250 created "2016-06-24" @default.
• W1970514250 creator A5010826355 @default.
• W1970514250 creator A5013708917 @default.
• W1970514250 creator A5041601065 @default.
• W1970514250 creator A5079478687 @default.
• W1970514250 creator A5086332857 @default.
• W1970514250 date "2008-10-06" @default.
• W1970514250 modified "2023-10-15" @default.
• W1970514250 title "Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients" @default.
• W1970514250 cites W1533510815 @default.
• W1970514250 cites W169479863 @default.
• W1970514250 cites W1798463198 @default.
• W1970514250 cites W1967968958 @default.
• W1970514250 cites W1993836870 @default.
• W1970514250 cites W1994783064 @default.
• W1970514250 cites W1995194361 @default.
• W1970514250 cites W2007424914 @default.
• W1970514250 cites W2011580699 @default.
• W1970514250 cites W2027322114 @default.
• W1970514250 cites W2032253481 @default.
• W1970514250 cites W2045930291 @default.
• W1970514250 cites W2054935116 @default.
• W1970514250 cites W2055810058 @default.
• W1970514250 cites W2064854769 @default.
• W1970514250 cites W2087576805 @default.
• W1970514250 cites W2117569778 @default.
• W1970514250 cites W2314227326 @default.
• W1970514250 cites W2327677963 @default.
• W1970514250 cites W2408122661 @default.
• W1970514250 cites W4252600625 @default.
• W1970514250 doi "https://doi.org/10.1186/1471-2253-8-6" @default.
• W1970514250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2576052" @default.
• W1970514250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18837982" @default.
• W1970514250 hasPublicationYear "2008" @default.
• W1970514250 type Work @default.
• W1970514250 sameAs 1970514250 @default.
• W1970514250 citedByCount "42" @default.
• W1970514250 countsByYear W19705142502012 @default.
• W1970514250 countsByYear W19705142502013 @default.
• W1970514250 countsByYear W19705142502014 @default.
• W1970514250 countsByYear W19705142502015 @default.
• W1970514250 countsByYear W19705142502016 @default.
• W1970514250 countsByYear W19705142502017 @default.
• W1970514250 countsByYear W19705142502018 @default.
• W1970514250 countsByYear W19705142502019 @default.
• W1970514250 countsByYear W19705142502020 @default.
• W1970514250 countsByYear W19705142502021 @default.
• W1970514250 countsByYear W19705142502022 @default.
• W1970514250 countsByYear W19705142502023 @default.
• W1970514250 crossrefType "journal-article" @default.
• W1970514250 hasAuthorship W1970514250A5010826355 @default.
• W1970514250 hasAuthorship W1970514250A5013708917 @default.
• W1970514250 hasAuthorship W1970514250A5041601065 @default.
• W1970514250 hasAuthorship W1970514250A5079478687 @default.
• W1970514250 hasAuthorship W1970514250A5086332857 @default.
• W1970514250 hasBestOaLocation W19705142501 @default.
• W1970514250 hasConcept C111113717 @default.
• W1970514250 hasConcept C112705442 @default.
• W1970514250 hasConcept C126322002 @default.
• W1970514250 hasConcept C142724271 @default.
• W1970514250 hasConcept C170493617 @default.
• W1970514250 hasConcept C204787440 @default.
• W1970514250 hasConcept C27081682 @default.
• W1970514250 hasConcept C2776452961 @default.
• W1970514250 hasConcept C2777953023 @default.
• W1970514250 hasConcept C2778938600 @default.
• W1970514250 hasConcept C2779867896 @default.
• W1970514250 hasConcept C2992203999 @default.
• W1970514250 hasConcept C42219234 @default.
• W1970514250 hasConcept C71924100 @default.
• W1970514250 hasConcept C84393581 @default.
• W1970514250 hasConceptScore W1970514250C111113717 @default.
• W1970514250 hasConceptScore W1970514250C112705442 @default.
• W1970514250 hasConceptScore W1970514250C126322002 @default.
• W1970514250 hasConceptScore W1970514250C142724271 @default.
• W1970514250 hasConceptScore W1970514250C170493617 @default.
• W1970514250 hasConceptScore W1970514250C204787440 @default.
• W1970514250 hasConceptScore W1970514250C27081682 @default.
• W1970514250 hasConceptScore W1970514250C2776452961 @default.
• W1970514250 hasConceptScore W1970514250C2777953023 @default.
• W1970514250 hasConceptScore W1970514250C2778938600 @default.
• W1970514250 hasConceptScore W1970514250C2779867896 @default.
• W1970514250 hasConceptScore W1970514250C2992203999 @default.
• W1970514250 hasConceptScore W1970514250C42219234 @default.
• W1970514250 hasConceptScore W1970514250C71924100 @default.
• W1970514250 hasConceptScore W1970514250C84393581 @default.
• W1970514250 hasIssue "1" @default.
• W1970514250 hasLocation W19705142501 @default.
• W1970514250 hasLocation W19705142502 @default.
• W1970514250 hasLocation W19705142503 @default.
• W1970514250 hasLocation W19705142504 @default.
• W1970514250 hasOpenAccess W1970514250 @default.
• W1970514250 hasPrimaryLocation W19705142501 @default.
• W1970514250 hasRelatedWork W1970514250 @default.
• W1970514250 hasRelatedWork W1997444466 @default.
• W1970514250 hasRelatedWork W2048018329 @default.
• W1970514250 hasRelatedWork W2254638634 @default.
• W1970514250 hasRelatedWork W2317064789 @default.
• W1970514250 hasRelatedWork W2369345461 @default.

• next